BRMEC4 Colloquium 2014

The fourth Invest in ME Research Biomedical Research into ME Colloquium (BRMEC4) took place in London over two days: 29th–30th May 2014.

Harnessing international collaboration to extend research cooperation and drive new biomedical ME research initiatives.

The research meeting was in London and preceded the IIMEC9 annual international biomedical research conference on 30th May 2014.

Almost 50 researchers from nine countries attended the colloquium and a number of new initiatives were created which will benefit biomedical research into ME.


BRMEC4 Agenda

Invest in ME BRMEC4
Welcome and introductions Co-Chairs: Dr. Ian Gibson Prof.Jonathan Edwards UCL
Pathogen Discovery and Pathogenesis - CFI Dr. Mady Hornig, Columbia Univ, USA
Infection-induced autoimmunity in ME Prof. Jonas Blomberg, Uppsala Univ, Sweden
Microbiome of ME/CFS patients Prof. Maureen Hanson, Cornell Univ.,USA
OMI research Update Dr Andreas Kogelnik, OMI, USA
Chaired Discussions Prof. Jonathan Edwards/Dr.Ian Gibson
Antibodies in Neurological Diseases Prof. Angela Vincent, Oxford Univ.
Rituximab multi-centre clinical trial Prof.Olav Mella/Dr. Oystein Fluge, Bergen, Norway
Rituximab UK clinical
- Preliminary B-cell study
Dr. Jo Cambridge, UCL, UK
EBV and ME Prof. Carmen Scheibenbogen, Charite, Berlin
Chaired Discussions Prof. Jonathan Edwards/Dr.Ian Gibson
Update on ANS studies Prof. Julia Newton, Newcastle, UK
Brain imaging and ME Prof. James Baraniuk Georgetown Univ., USA
NK-, B- and T-cell phenotypes and function in patients suffering from ME Prof. Sonya Marshall-Gradisnik, Griifiths Univ.,Australia
ME Biobank Dr. Eliana Lacerda/Dr Luis Nacul, LSHTM
Chaired Discussions Prof. Jonathan Edwards/Dr.Ian Gibson
Ways to Continue Collaboration and Discovery Funding Possibilities - IiME Proposal Plenary: Prof. Jonathan Edwards/Dr.Ian Gibson
Closing Summary and Future Directions Prof. Jonathan Edwards/Dr.Ian Gibson Briefing to Invest in ME Conference


Share this page:

Last updated: December 2025